Researchers at Colorado State University have developed an aerosol chamber for delivering low doses of dry powder medications to animals. The chamber allows long-term drug studies at biologically meaningful levels while keeping animals calm and unstressed. This design improves the relevance of preclinical studies by reducing stress-related variables. It also enables more precise dosing and multiple treatment sessions with minimal drug waste.
Preclinical testing of inhaled dry powders has been limited by a lack of suitable delivery devices. Current systems require large amounts of drug and restraining animals, creating stress that can compromise long-term studies. There is a need for methods that allow repeated, controlled dosing without causing stress, especially for compounds that are costly, scarce, or not yet mass-produced.
The aerosol chamber enables passive inhalation of dry powders within a calm, semi-anesthetized environment. By maintaining the drug in a standing aerosol cloud, the system recycles the powder, dramatically reducing the quantity needed to achieve biologically active dosing. This makes it feasible to study expensive or limited-availability compounds efficiently.
Unlike traditional methods that require animal restraint, this chamber allows multiple doses over extended periods while keeping subjects relaxed. This supports studies that better mimic clinical drug delivery, reduces confounding stress effects, and enhances the reliability of preclinical data. Quantitative improvements include lower drug consumption per study and the ability to sustain long-term dosing protocols that were previously impractical.
Available for Non-Exclusive Licensing
TRL: 7
Know-How
Mercedes Gonzalez-Juarrero
Jeffrey Mariner Gonzalez
Jessy McGowan
Jessy.McGowan@colostate.edu
970-491-7100